METADOZE? IPR

Biocon offers a wide range of metabolic which includes metadoze ipr. Composition: metformin 850mg tablets with ipr (immediate and patterned release technology) and metformin 500mg tablets with ipr (immediate and patterned release technology). Mechanism of action: metformin, belonging to the class of anti-diabetes drugs, biguanides, improves insulin sensitivity. Its extra pancreatic actions include reduction of hepatic glucose production, potentiation of insulin actions, increased peripheral utilisation of glucose and delayed intestinal absorption of sugars and starches. Indications: first line anti-diabetic, used as a single drug or in combination with other drugs e.g. Glimepiride, pioglitazone etc. To control blood glucose levels, metadoze ipr incorporates a unique ipr technology which enables 30% immediate and 70% patterned release of metformin. This not only makes metformin longer acting, but also improves absorption and reduces side effects